Jump to content

HLA-DRB1

From Wikipedia, the free encyclopedia
(Redirected from HLA-DRB1:01:01)

HLA-DRB1
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesHLA-DRB1, DRB1, DRw10, HLA-DR1B, HLA-DRB, SS1, major histocompatibility complex, class II, DR beta 1
External IDsOMIM: 142857; MGI: 95901; HomoloGene: 136635; GeneCards: HLA-DRB1; OMA:HLA-DRB1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001243965
NM_002124
NM_001359193
NM_001359194

NM_010382

RefSeq (protein)

NP_001230894
NP_002115
NP_001346122
NP_001346123
NP_002115.2

NP_034512

Location (UCSC)Chr 6: 32.58 – 32.59 MbChr 17: 34.52 – 34.54 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

HLA class II histocompatibility antigen, DRB1 beta chain is a protein that in humans is encoded by the HLA-DRB1 gene.[5] DRB1 encodes the most prevalent beta subunit of HLA-DR. DRB1 alleles, especially those encoding amino acid sequence changes at positions 11 and 13, are associated risk of rheumatoid arthritis.[6][7]

Function

[edit]

The protein encoded by this gene belongs to the HLA class II beta chain paralogues. The class II molecule is a heterodimer consisting of an alpha (DRA) and a beta chain (DRB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins to T helper cells. Class II molecules are constitutively expressed in professional antigen-presenting cells (APC: B lymphocytes, dendritic cells, macrophages),[5] and could be induced in non-professional APCs.

There is evidence it is associated with reduced severity of COVID-19 disease.[8]

Gene structure and polymorphisms

[edit]

The beta chain is approximately 26-28 kDa. It is encoded by 6 exons, exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. To date, more than 3,700 HLA-DRB1 alleles have been described and made publicaly available in the IPD-IMGT/HLA Database.[9] HLA typing for these polymorphisms is routinely done for bone marrow and kidney transplantation.[5]

Gene expression

[edit]

DRB1 is expressed at a level five times higher than its paralogues DRB3, DRB4 and DRB5. DRB1 is present in all individuals. Allelic variants of DRB1 are linked with either none or one of the genes DRB3, DRB4 and DRB5. There are 5 related pseudogenes: DRB2, DRB6, DRB7, DRB8 and DRB9.[5]

Prevalence of the HLA-DRB1*10:01 allele was greatly increased in people with anti-IgLON5 disease.[10]

See also

[edit]

References

[edit]
  1. ^ a b c ENSG00000206240, ENSG00000229074, ENSG00000196126, ENSG00000206306, ENSG00000228080 GRCh38: Ensembl release 89: ENSG00000236884, ENSG00000206240, ENSG00000229074, ENSG00000196126, ENSG00000206306, ENSG00000228080Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000060586Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b c d "Entrez Gene: HLA-DRB1 major histocompatibility complex, class II, DR beta 1".
  6. ^ Gregersen PK, Silver J, Winchester RJ (November 1987). "The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis". Arthritis and Rheumatism. 30 (11): 1205–13. doi:10.1002/art.1780301102. PMID 2446635.
  7. ^ Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, et al. (January 2012). "Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis". Nature Genetics. 44 (3): 291–296. doi:10.1038/ng.1076. PMC 3288335. PMID 22286218.
  8. ^ Langton DJ, Bourke SC, Lie BA, Reiff G, Natu S, Darlay R, et al. (July 2021). "The influence of HLA genotype on the severity of COVID-19 infection". HLA. 98 (1): 14–22. doi:10.1111/tan.14284. PMC 8251294. PMID 33896121.
  9. ^ Barker DJ, Maccari G, Georgiou X, Cooper MA, Flicek P, Robinson J, et al. (January 2023). "The IPD-IMGT/HLA Database". Nucleic Acids Research. 51 (D1): D1053–D1060. doi:10.1093/nar/gkac1011. PMC 9825470. PMID 36350643.
  10. ^ Gaig C, Graus F, Compta Y, Högl B, Bataller L, Brüggemann N, et al. (May 2017). "Clinical manifestations of the anti-IgLON5 disease". Neurology. 88 (18): 1736–1743. doi:10.1212/WNL.0000000000003887. PMC 5409845. PMID 28381508.

Further reading

[edit]